Role of Sodium-Glucose Co-Transporter 2 Inhibitors in Chronic Kidney Disease, Congestive Heart Failure and Stroke—A Review and Clinical Guide for Healthcare Professionals

Diabetic kidney disease (DKD) causes a progressive decline in renal function, leading to end-stage kidney disease (ESKD), and increases the likelihood of cardiovascular events and mortality. The recent introduction of the sodium-glucose co-transporter 2 (SGLT-2) inhibitor has been a game changer in...

Descripción completa

Detalles Bibliográficos
Autores principales: Singh, Prabhat, Goyal, Lokesh, Mallick, Deobrat C., Surani, Salim R., Yashi, Kanica
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2023
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10574010/
https://www.ncbi.nlm.nih.gov/pubmed/37834846
http://dx.doi.org/10.3390/jcm12196202

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10574010/
https://www.ncbi.nlm.nih.gov/pubmed/37834846
http://dx.doi.org/10.3390/jcm12196202

Ejemplares similares